Metric Analysis: Jaguar Health Inc (JAGX)’s Key Ratios in the Limelight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

In the latest session, Jaguar Health Inc (NASDAQ: JAGX) closed at $3.56 up 4.40% from its previous closing price of $3.41. In other words, the price has increased by $4.40 from its previous closing price. On the day, 0.24 million shares were traded. JAGX stock price reached its highest trading level at $3.53 during the session, while it also had its lowest trading level at $3.4.


For a deeper understanding of Jaguar Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.89. In the meantime, Its Debt-to-Equity ratio is 2.31 whereas as Long-Term Debt/Eq ratio is at 1.56.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.

On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 17112304 and an Enterprise Value of 41201356. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.68 while its Price-to-Book (P/B) ratio in mrq is 1.35. Its current Enterprise Value per Revenue stands at 4.063 whereas that against EBITDA is -1.361.

Stock Price History:

The Beta on a monthly basis for JAGX is 0.88, which has changed by -0.8878205 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, JAGX has reached a high of $41.76, while it has fallen to a 52-week low of $3.07. The 50-Day Moving Average of the stock is -58.72%, while the 200-Day Moving Average is calculated to be -66.59%.

Shares Statistics:

For the past three months, JAGX has traded an average of 1.07M shares per day and 419070 over the past ten days. A total of 4.79M shares are outstanding, with a floating share count of 4.18M. Insiders hold about 12.63% of the company’s shares, while institutions hold 2.03% stake in the company. Shares short for JAGX as of 1718323200 were 353382 with a Short Ratio of 0.33, compared to 1715731200 on 211758. Therefore, it implies a Short% of Shares Outstanding of 353382 and a Short% of Float of 7.23.

Most Popular